Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-24

Clinical Trial Update: Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing patient-controlled analgesia versus bolus narcotic therapy for vaso-occlusive crisis in sickle cell disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: Sickle Cell Disease, Vaso-occlusive Crisis | Phase 2 | Status: WITHDRAWN